source
- Merck and Moderna disclose phase 3 cancer vaccine data early after leak, showing improved recurrence-free survival with KeytrudaMerck & Co. and Moderna were forced to release their phase 3 trial results for the intismeran autogene cancer vaccine two days ahead of schedule after an unexpected leak of the data ahead of the ES…
- Amgen and AstraZeneca present new combo data for extensive-stage small cell lung cancer at ESMODay two of the European Society for Medical Oncology meeting in Madrid saw nearly 40,000 attendees gathering for the latest cancer research updates, as reported in the STAT+ newsletter. The sessio…